製品の概要

  • 製品名HENECA
  • 製品の詳細
    Selective A2A receptor agonist
  • 生理活性の詳細Selective A2A receptor agonist (Ki = 2.2 nM). Shows good selectivity for A2A over A1 receptors. Displays antiaggregatory activity. Increases cAMP accumulation (EC50 = 43 nM) and inhibits superoxide anion production (EC50 = 3.63 nM) in neutrophils.
  • 精製度> 99%

製品の特性

    HENECA (ab120458) 使用論文

    This product has been referenced in:
    • Varani K  et al. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol 136:57-66 (2002). Read more (PubMed: 11976268) »
    • Varani K  et al. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation 102:285-9 (2000). Read more (PubMed: 10899090) »
    • Monopoli A  et al. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine. Arzneimittelforschung 44:1296-304 (1994). Read more (PubMed: 7848347) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120458.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"